The Role of Antimuscarinics in the Management of Men With Symptoms of Overactive Bladder Associated With Concomitant Bladder Outlet Obstruction: An Update
- 31 July 2011
- journal article
- review article
- Published by Elsevier BV in European Urology
- Vol. 60 (1), 94-105
- https://doi.org/10.1016/j.eururo.2011.03.054
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Antimuscarinic Mechanisms and the Overactive Detrusor: An UpdateEuropean Urology, 2011
- Basic mechanisms of urgency: roles and benefits of pharmacotherapyWorld Journal of Urology, 2009
- Urodynamic parameters after solifenacin treatment in men with overactive bladder symptoms and detrusor underactivityNeurourology and Urodynamics, 2009
- Extended‐release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom ScoreBJU International, 2008
- Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacinInternational Journal of Clinical Practice, 2008
- Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladderBritish Journal of Pharmacology, 2006
- Pathophysiology of Overactive BladderAmerican Journal Of Medicine, 2006
- A Shifted Paradigm for the Further Understanding, Evaluation, and Treatment of Lower Urinary Tract Symptoms in Men: Focus on the BladderEuropean Urology, 2006
- Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladderBJU International, 2004
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002